Paper2437455
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
Williams SD and 5 others. N Engl J Med, 1987. Cited by 1,031 papers, by iCite.
Cite this record
ConductScience Library. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. Papers, record 2437455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2437455
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Neoplasms, Germ Cell and Embryonal | Major topic |
| Bleomycin | |
| Cisplatin | |
| Clinical Trials as Topic | |
| Drug Administration Schedule | |
| Etoposide | |
| Female | |
| Humans | |
| Male | |
| Random Allocation | |
| Vinblastine |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 2 R35 CA 39844-02 | NCI NIH HHS | United States | R35CA398440 | PubMed | NIH RePORTER |
| CA 24456 | NCI NIH HHS | United States | R10CA024456 | PubMed and NIH | NIH RePORTER |
| MO 1-RR00-750-15 | NCRR NIH HHS | United States | MO1RR007501 | PubMed | NIH RePORTER |
| M01RR000750 | NIH | NIH RePORTER | |||
| R35CA039844 | NIH | NIH RePORTER | |||
| U10CA024456 | NIH | NIH RePORTER |
Cited by208
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,031 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42271363 | Clinical outcomes of a 3-day modified BEP regimen in malignant ovarian germ cell tumors in a single-center real-world study. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42271363 | PubMed |
| 41001186 | Updates in the Management of Malignant Ovarian Germ Cell Tumors. | O G Open | 2025 | https://conductscience.org/library/papers/41001186 | PubMed |
| 40947516 | Outcome of Children With Intermediate-Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group. | Pediatr Blood Cancer | 2025 | https://conductscience.org/library/papers/40947516 | PubMed |
| 40572639 | Survival Outcomes in Metastatic Germ Cell Tumors: A Multicenter Study from Turkey. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40572639 | PubMed |
| 40515472 | Adverse health outcomes in testis cancer survivors-the price for our success? | Oncologist | 2025 | https://conductscience.org/library/papers/40515472 | PubMed |
| 40098231 | Standard-Dose Versus High-Dose Cisplatin for Intermediate/Poor-Risk Extracranial Malignant Germ Cell Tumors: Re-Analysis of Pediatric Oncology Group 9049 and Children's Cancer Group 8882 Trial Using Updated MaGIC Risk Stratification. | Pediatr Blood Cancer | 2025 | https://conductscience.org/library/papers/40098231 | PubMed |
| 39432183 | The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/39432183 | PubMed |
| 39386925 | Treatment of recurrent ovarian germ cell tumours: Is there a role for immune checkpoint inhibitors? | Gynecol Oncol Rep | 2024 | https://conductscience.org/library/papers/39386925 | PubMed |
| 39046545 | Detection of vinblastine and related bioactive compounds from culture extracts of endophytic fungi of Catharanthus roseus. | World J Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/39046545 | PubMed |
| 38929965 | Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. | J Clin Med | 2024 | https://conductscience.org/library/papers/38929965 | PubMed |
| 38074010 | Testicular Germ Cell Tumors in Children and Adolescents Treated With Bleomycin, Etoposide, and Cisplatin (BEP) Protocol: A Survival Analysis. | Cureus | 2023 | https://conductscience.org/library/papers/38074010 | PubMed |
| 37564420 | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States. | Lancet Reg Health Am | 2023 | https://conductscience.org/library/papers/37564420 | PubMed |
| 37149691 | Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. | Nat Commun | 2023 | https://conductscience.org/library/papers/37149691 | PubMed |
| 37046659 | Pediatric Extracranial Germ Cell Tumors: Review of Clinics and Perspectives in Application of Autologous Stem Cell Transplantation. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37046659 | PubMed |
| 36947730 | The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/36947730 | PubMed |
| 36882564 | Treatment de-escalation for stage II seminoma. | Nat Rev Urol | 2023 | https://conductscience.org/library/papers/36882564 | PubMed |
| 36477219 | High-dose chemotherapy for relapsed testicular germ cell tumours. | Nat Rev Urol | 2023 | https://conductscience.org/library/papers/36477219 | PubMed |
| 36340558 | Bleomycin-Induced Fulminant Hyperpyrexia: A Report of Two Cases and Review of Literature. | Cureus | 2022 | https://conductscience.org/library/papers/36340558 | PubMed |
| 35111449 | From Cancer Patient to Provider: An Autobiographical Case Report. | Cureus | 2021 | https://conductscience.org/library/papers/35111449 | PubMed |
| 34738090 | Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial. | Eur Urol Open Sci | 2021 | https://conductscience.org/library/papers/34738090 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2437455
GET https://conductscience.org/api/papers/v1/2437455/cited_by?page=2